Epidemiology, pathophysiology and contemporary management of cardiogenic shock–a position statement from the Heart Failure Association of the European Society …

O Chioncel, J Parissis, A Mebazaa… - European journal of …, 2020 - Wiley Online Library
Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, developing as a continuum, and progressing from the initial insult (underlying …

Vasoactive-inotropic score: evolution, clinical utility, and pitfalls

A Belletti, CC Lerose, A Zangrillo, G Landoni - Journal of cardiothoracic and …, 2021 - Elsevier
Inotropes and vasopressors frequently are administered in critically ill and perioperative
patients. However, clinical practice is highly variable across clinicians and institutions. The …

[PDF][PDF] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

P Ponikowski, AA Voors, SD Anker… - Kardiologia Polska …, 2016 - journals.viamedica.pl
5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: Expert opinion of the Working Group on Prevention, AKI …

M Joannidis, W Druml, LG Forni, ABJ Groeneveld… - Intensive care …, 2017 - Springer
Background Acute kidney injury (AKI) in the intensive care unit is associated with significant
mortality and morbidity. Objectives To determine and update previous recommendations for …

[HTML][HTML] Levosimendan for hemodynamic support after cardiac surgery

G Landoni, VV Lomivorotov, G Alvaro… - … England Journal of …, 2017 - Mass Medical Soc
Background Acute left ventricular dysfunction is a major complication of cardiac surgery and
is associated with increased mortality. Meta-analyses of small trials suggest that …

Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use

Z Papp, P Agostoni, J Alvarez, D Bettex… - Journal of …, 2020 - journals.lww.com
Levosimendan was first approved for clinical use in 2000, when authorization was granted
by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely …

Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure

M Packer, W Colucci, L Fisher, BM Massie… - JACC: Heart Failure, 2013 - jacc.org
Background: This study evaluated the efficacy and safety of levosimendan, a positive
inotropic drug with vasodilator effects, given intravenously to patients with acutely …

Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

SE de Cardiología, Heart Failure Association - 2021 - dspace.uniandes.edu.ec
Las guías de práctica clínica (GPC) tienen como objetivo reunir y evaluar toda la evidencia
relevante disponible durante el proceso de elaboración sobre un tema particular para …

Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION‐HEART multicentre …

J Comín‐Colet, N Manito… - European journal of …, 2018 - Wiley Online Library
Aims The LION‐HEART study was a multicentre, double‐blind, randomised, parallel‐group,
placebo‐controlled trial evaluating the efficacy and safety of intravenous administration of …

Pulmonary surfactant: A mighty thin film

F Possmayer, YY Zuo, RAW Veldhuizen… - Chemical …, 2023 - ACS Publications
Pulmonary surfactant is a critical component of lung function in healthy individuals. It
functions in part by lowering surface tension in the alveoli, thereby allowing for breathing …